Azapharm’s Post

European startup funding faltered in Q3 2024, with startups raising a total of $11.3 billion – down 35% compared to the same time last year according to Dealroom.co 🇪🇺 🚀     In this context, the healthtech sector experienced an unexpected comeback, securing more VC than any other sector during the year to date. Other sectors like AI technologies and fintech also grew. Imran Ghory, Partner at Blossom Capital, said: “There is a strong pipeline of innovative companies being forged across the continent and it’s not surprising that AI is playing a huge role in this.” Remus Brett, General Partner at LocalGlobe and Latitude, added: “Europe’s fintech sector is back in full force, as these funding figures confirm. Fintech startups, most now AI first, are further accelerating B2C and B2B innovation and opening up more opportunities in this $30 trillion sector.”

Accel is back with the fourth cohort of their pre-seed accelerator - Accel Atoms. Over the last 3 cohorts, they’ve funded 30+ startups who’ve collectively raised more than $200 Million. With their fourth cohort, they’re looking to invest in founders building in two thriving sectors - AI & Bharat. What is the AI opportunity? 🤖 Microprocessors led the first tech revolution, which was followed by the internet. The third tech revolution is led by Artificial Intelligence (AI). This is a global opportunity for any Indian-origin founder to build AI applications for business cases or to build development/foundational tools in the AI ecosystem. What is the Bharat opportunity? The top 20% of the rural population has a higher monthly per capita expenditure (MPCE) than about 50% of the urban population. This highlights the substantial purchasing power & opportunity that is often overlooked in Bharat. Who should apply for Accel Atoms? 📝 Accel Atoms is looking for ambitious founders with an ambitious idea in AI or Bharat. This includes startups at the pre-seed stage and startups in the idea-stage/pre-product stage. Why should you apply for Accel Atoms? 🤔 When selected, you’ll receive up to $1 Million in funding, perks worth $5 Million & access to a community of 300+ founders. You will also get access to a dedicated learning track to set up your startup for long-term success. Applications are open till the 17th Nov. You can learn more and apply for this program here: https://lnkd.in/gD7tXkRG #AccelAtoms #Headstart #Founders #Startups #Grow #Innovation

The continued interest in all things AI was also reflected in last week’s largest U.S. startup funding deals. After a slowdown in big rounds the week before, investors were once again dishing out nine-figure rounds — all told, seven companies raised $100 million or more apiece. Some of the largest rounds went to startups using AI in coding or biotech. #vc #startups https://lnkd.in/gERBEB26

Unlabeled funding rounds are in decline. And that's a good thing. Unlabeled rounds often increase during transitional periods in market conditions, when startups require capital but haven't yet achieved the necessary milestones for their next funding round. While the number of these unlabeled rounds is still significant, it is clearly declining from its peak. This trend suggests a return to more traditional and transparent funding patterns, where both investors and startups are aligning expectations more closely. Read more about these funding trends and how you can use investment capital to make sure you meet the milestones investors expect. https://lnkd.in/ewdKZNPn #MedTech #Innovation #VentureCapital #AI #MedicalDevice #Startups

North American Startup Funding Sees Significant Surge in Q2 2024 In the second quarter of 2024, North American startup funding experienced a significant increase, rising by 30% from the previous quarter and 35% from the same period last year, totaling $45.3 billion. This surge was primarily driven by early-stage investments in artificial intelligence (AI), with AI-focused startups attracting $16.8 billion. Notably, xAI, led by Elon Musk, secured over 25% of all early-stage funding, highlighting the sector's dominance. Despite this growth, investment in sectors such as enterprise software, consumer products, and fintech remained relatively restrained, and the number of reported deals declined to a multi-year low. Late-stage investments saw a slight uptick to $19.4 billion, while early-stage funding surged by 60% to reach $22 billion. Seed-stage investments remained stable at $3.9 billion, although the number of deals decreased slightly. Exit activity was subdued, with notable acquisitions including Hg's $3 billion purchase of AuditBoard and Merck's $1.3 billion acquisition of EyeBio. IPO activity featured Rubrik raising $752 million and Tempus, a Google-backed AI precision medicine startup, raising $410 million. The overall landscape presents a mixed picture: strong investment and robust AI funding contrast with weaker funding in other sectors and a backlog of mature startups lacking exits. Optimism prevails, particularly due to AI's potential, although many startups and industries are yet to benefit from this bullish trend. # Thank you Emilia Diaz for your submission!

A strong #TechWeekInReview with over 5 million euro in search by sharply evolving startups. A symbolic boom on the last miles of a challenging year. ➡FieldOS raised 500k euro through BCR Seed Starter fund. Founded. The startup offers a SaaS platform for managing field activities and asset maintenance. The funding will be used to develop the product further, accelerate growth in the local market, and expand operations into North America. FieldOS aims to double its annual revenue to approximately €400,000 by the end of 2024 and increase its client base to over 20 companies across various sectors, including retail, facility management, education, security services, and HoReCa. ➡parol, a startup that automates medical documentation using artificial intelligence, has secured €1.2 million in funding. Parol's platform transcribes real-time conversations between doctors and patients, generating complete and accurate medical records within seconds. This technology aims to reduce the administrative burden on healthcare professionals, allowing them to focus more on patient care. The investment will support further development of the platform and expansion into new markets. ➡Nordensa®, which has developed a fan-powered platform for football talent discovery, has raised €1.8 million as part of a pre Series A funding round. The company plans to raise an additional €490,000 through individual investors on the SeedBlink platform. Nordensa's platform enables football fans to invest in emerging talents, potentially earning a share of the players' future earnings. The funds will be used to expand operations, establish new partnerships with football clubs, and further develop the platform. The company is currently valued at €12 million pre-investment. ➡Naratix, a Romanian startup specializing in AI-powered robots for the e-commerce industry, is currently seeking to raise $2-3 million in funding. The company has developed five AI robots, with two—Nara and Dynamo—already available to clients. Nara generates product descriptions, while Dynamo enriches product data by sourcing information such as images, prices, and attributes. Naratix has over 500 active direct clients and a network of more than 125 partners and clients across 30 countries. The funds will be used to expand the team, continue product development, and enhance marketing efforts. ➡Medicai plans to expand into the U.S. market in 2025 when it also aims to raise a new funding round to support this growth. Medicai, a startup offering a platform for managing medical imaging data, has doubled its revenues over the past year and now administers over 2 million imaging studies in Romania. The platform facilitates the transfer, visualization, storage, and sharing of medical imaging data, improving coordination among healthcare providers. #growingtogether #startups #angelinvestors #growsmart #smartgrowth

Exciting news for the EU AI start-up scene! 🥳 This new accelerator program for companies who use open-source AI is a promising development (especially for European companies). While I'm currently pursuing incorporation with a C corporation and other opportunities in the US, I'm still excited to see how this initiative boosts the EU AI scene! 🦄 A total of five startups in the MVP stage will be selected to undertake the programme so make sure to bring your A game. 🔥 For those applying, what aspect of the program are you most excited about (mentorship, funding, networking, etc.) and why? 🤔 #AI #Startups #OpenSource #AcceleratorProgram #EUTech #Entrepreneurship #Innovation #TechNews #AIStartups #EuropeanStartups #Mentorship #Funding #Networking

This year, Sifted has tracked 686 rounds worth €3.1bn raised by european startups launched in 2023 or 2024: here’s what they’re up to, plus a free downloadable list of all tracked fundraises. 📈 #EU #europe #EuropeanStartups #aistartups #deeptech #capitalmarkets #startupfunding #techstartups #vcfunding #AI #artificialintelligence #aitechnology #aipowered #vctrends #aiguided #generativeai #genai #aiinvestments #aibusiness #startup #saasstartups #businessexpansion #startupgrowth #vc #venture #fundraising #funding #capitalraising #earlystagestartups #pe #privateequity #angelinvestors #startupfinancing #venturefunding #venturecapital #investors #startupecosystem #marketdata #innovationecosystem #scaleups #freedownload #list

H1 MedTech Funding: A Light at the End of the Tunnel? 🚨 Three recent reports present slightly different views of the market, but all point to encouraging trends. 📈 Overall growth: The first half of 2024 has shown promising signs for MedTech startups, with US venture funding on pace to a potential 20% annual growth over last year. 🌱 Early-stage funding is back: With $2.4 billion in seed and A round investments, early-stage funding is on track to surpass the past two years. ⚠Challenges remain: Despite the positive trends, MedTech startups must still act strategically to maximize the impact of their funding and secure additional rounds. How can medical device innovators secure and optimize new funding? #MedTech #Innovation #VentureCapital #AI #MedicalDevice #Startups

AIM Research has just released our report on the 'Gen AI Startup Landscape in India - 2024'. The report showcases the explosive growth of Gen AI startups, driven by VCs and tech talent in hubs like Bengaluru and Delhi-NCR. It highlights the key players, the surge in early-stage funding, and India’s rising influence in the global Gen AI landscape. Read the complete report here: https://lnkd.in/ga-ysxVr Some of the Key Highlights of the Report are: 1. The global Gen AI market is projected to grow from USD 39.2 billion in 2023 to USD 1,082.4 billion by 2033. The market is anticipated to expand at a CAGR of 40.22% from 2024 to 2033. 2. There are over 150 Gen AI startups currently operating in India as of August 2024 3. 51.4% of India’s Gen AI startups are based in Bengaluru, positioning the city as a leading hub for Gen AI startups in the country. 4. Gen AI startups such as Krutrim AI, Sarvam AI, Ema Unlimited, Neysa Networks, RagaAI Inc have all received substantial funding in 2024. 5. 54.0% of AI startups obtained funding in their seed round. Some of the other key Gen AI Startups: TWO.AI, gnani.ai, SocketLabs, Uniphore, Subtl.ai | Perplexity style engines for everyone, Exotel, upliance.ai Leena AI, SML, TurboML, KissanAI, CoRover, Intello Labs, Beatoven.ai, Devnagri AI Top Investors in the GenAI StartUps: Lightspeed, Nexus Venture Partners, Peak XV Partners, pi Ventures, Sequoia Capital, Khosla Ventures, Y Combinator, Inflection Point Ventures, Google for Startups #GenAIStartups #StartupLandscapeIndia #GenAIStartupsinIndia #AIStartups #BestfirmCertification #AIM